NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Published 18/09/2023, 11:34
© Reuters.  Alteryx, Iovance Biotherapeutics And Other Big Stocks Moving Higher In Monday's Pre-Market Session
H
-
IOVA
-
KRP
-
AYX
-
NKLA
-
BITF
-

Benzinga - by Lisa Levin, Benzinga Editor.

U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording gains in today’s pre-market trading session.

  • Newegg Commerce, Inc. (NASDAQ: NEGG) shares climbed 8.7% to $1.12 in pre-market trading after falling 5% on Friday.
  • Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) shares rose 7.2% to $5.65 in pre-market trading. Iovance Therapeutics shares jumped 13% on Friday after the company announced the FDA extended its BLA Priority Review for lifileucel amid resource constraints.
  • Bitfarms Ltd. (NASDAQ: BITF) shares gained 6% to $1.24 in pre-market trading.
  • Nikola Corporation (NASDAQ: NKLA) rose 5.9% to $1.26 in pre-market trading after gaining over 3% on Friday.
  • Alteryx, Inc. (NYSE: AYX) shares gained 5.2% to $36.67 in pre-market trading. Morgan Stanley upgraded Alteryx from Equal-Weight to Overweight and announced a $54 price target.
  • TeraWulf Inc. (NASDAQ: WULF) shares rose 4.7% to $1.76 in pre-market trading. TeraWulf recently announced Aug. 2023 production and operations updates.
  • Hyatt Hotels Corporation (NYSE: H) shares climbed 4.7% to $112.54 in pre-market trading.
  • Kimbell Royalty Partners, LP (NYSE: KRP) shares gained 4.6% to $16.25 in pre-market trading. Kimbell Royalty Partners recently closed $455 million acquisition of Permian and Mid-Con mineral and royalty interests in cash transaction.
  • Calliditas Therapeutics AB (NASDAQ: CALT) shares gained 4.5% to $16.76 in pre-market trading. Calliditas Therapeutics is making significant strides in addressing rare kidney diseases. In a recent interview with Benzinga, the company’s CEO, Renee Aguiar-Lucander, provided valuable insights on various aspects of its work.
Now Read This: Investor Sentiment Declines After S&P 500 Falls For Second Straight Week

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.